Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Review

Emerging treatments in type 2 diabetes: focus on canagliflozin

       
Total article views   HTML views PDF downloads Totals
11,630 Dovepress* 9,476+ 2,451 11,927
PubMed Central* 2,154 968 3,122
Totals 11,630 3,419 15,049
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar